BRIEF published on 04/18/2026 at 01:40, 2 months 26 days ago Medicure annonce un changement de direction Medicure Inc. Médicaments Changement De Leadership Priorités Stratégiques Marché Des États-Unis
PRESS RELEASE published on 04/18/2026 at 01:35, 2 months 26 days ago Medicure Announces Resignation of President and Chief Operating Officer Medicure Inc. announces resignation of President and COO, Dr. Neil Owens. CEO Dr. Albert D. Friesen to assume responsibilities. Company remains focused on strategic priorities for the future Pharmaceuticals Resignation Healthcare Medicure Inc. Leadership
BRIEF published on 11/19/2025 at 23:05, 7 months 24 days ago Les résultats financiers de Medicure pour le troisième trimestre 2025 reflètent une croissance du chiffre d'affaires malgré une perte nette. Marley Drug Croissance Des Revenus Perte Nette Ventes D'AGGRASTAT® Résultats Financiers De Mediure
BRIEF published on 11/19/2025 at 23:05, 7 months 24 days ago Medicure's Q3 2025 Financial Results Reflect Revenue Growth Despite Net Loss Revenue Growth Marley Drug Net Loss AGGRASTAT® Sales Medicure Financial Results
PRESS RELEASE published on 11/19/2025 at 23:00, 7 months 24 days ago Medicure Reports Financial Results for Quarter Ended September 30, 2025 Medicure Inc. reports Q3 2025 results with total net revenue of $8.2 million, an overview of financial performance and key highlights Financial Performance Medicure Inc. Net Revenue Q3 2025 Results Highlights
BRIEF published on 11/13/2025 at 23:35, 8 months ago Medicure to Announce Q3 2025 Financial Results on November 20 Financial Results Conference Call Medicure Inc. U.S. Pharmaceuticals AGGRASTAT® And ZYPITAMAG®
BRIEF published on 11/13/2025 at 23:35, 8 months ago Medicure annoncera ses résultats financiers du troisième trimestre 2025 le 20 novembre Résultats Financiers Medicure Inc. Conférence Téléphonique Produits Pharmaceutiques Américains AGGRASTAT® Et ZYPITAMAG®
PRESS RELEASE published on 11/13/2025 at 23:30, 8 months ago Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025 Medicure Inc. will present Financial Results for Q3 2025 on November 20, 2025, focusing on pharmaceutical development and commercialization in the U.S. market Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 08/20/2025 at 23:35, 10 months 24 days ago Medicure publie ses résultats financiers du deuxième trimestre 2025 Résultats Financiers Perte Nette Revenu Net Investissement Dans La Recherche Entreprise Pharmaceutique
BRIEF published on 08/20/2025 at 23:35, 10 months 24 days ago Medicure Reports Q2 2025 Financial Results Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
Published on 07/14/2026 at 16:40, 5 hours ago AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation
Published on 07/14/2026 at 15:45, 5 hours 55 minutes ago Silver Storm Commences Hot Commissioning of the La Parrilla Sulphide Circuit, Amends the Samsung Prepayment Agreement, and Secures US$5 Million Loan from First Majestic
Published on 07/14/2026 at 15:15, 6 hours 25 minutes ago Gratomic Inc. Provides Corporate Update for Shareholders
Published on 07/14/2026 at 15:00, 6 hours 40 minutes ago Four Nines Gold Engages Drill Contractor as Hayden Hill Enters First Modern Drill Campaign in Nearly Three Decades
Published on 07/14/2026 at 14:00, 7 hours 40 minutes ago First Canadian Graphite Appoints Tony La Mantia to Advisory Board
Published on 07/14/2026 at 19:14, 2 hours 26 minutes ago EQS-Adhoc: Nagarro SE: BaFin Enforcement Review of the 2022 Consolidated Financial Statements
Published on 07/14/2026 at 18:17, 3 hours 22 minutes ago EQS-Adhoc: Delivery Hero confirms advanced negotiations with Uber Technologies in respect to potential takeover offer
Published on 07/14/2026 at 17:51, 3 hours 48 minutes ago Aumann announces share buyback with an allotment ratio of approximately 6%
Published on 07/14/2026 at 17:30, 4 hours 10 minutes ago NABR: The U.S. Fish and Wildlife Service for the Second Time Rejects Activists' Petition to List Long-Tailed Macaque Monkeys Under the Endangered Species Act
Published on 07/14/2026 at 17:28, 4 hours 12 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 07/13/2026 at 18:00, 1 day 3 hours ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 1 day 3 hours ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 1 day 3 hours ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
